The authors suggest that the cytoprotective properties of ASM downregulation in cancer cells are related to the secreted form of the enyzme, which generates ceramide at the plasma membrane, whilst lysosomal ASM is needed for lysosomal integrity and cell viability. This evidence concerns the gene SMPD1 and cancer.